Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Test if aging changes how brain rhythms coordinate vision, and try a tailored brain stimulation to help with vision in older adults

Official title: Rescuing Visual Perception in Aging Adults by Restructuring the Alpha-Gamma Neural Code

Run by Boston University Charles River Campus · NCT07208318 · Data updated 2026-11-12

This study tests whether age-related visual problems come from disrupted alpha-gamma brain rhythms in the visual cortex and uses personalized high-definition tACS to try to improve vision in older adults.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment240 (estimated)
SponsorBoston University Charles River Campus
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedApril 2, 2026
Main results expectedAugust 31, 2030
Study endsAugust 31, 2030
Registry record updatedJuly 16, 2026
Trial IDNCT07208318 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older with normal or corrected visual acuity who do not have major neurological or ophthalmologic conditions and meet safety criteria.

Probably not a fit

Individuals with certain neurological, psychiatric, or ocular diseases or those on psychoactive meds may not experience benefits and may be excluded from benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Two five-day, double-blind, sham-controlled studies will test whether aging alters alpha-gamma coupling in early visual areas (V1) and in MT during 3D shape-from-motion tasks. The approach combines structural/functional MRI, high-density EEG with source localization, and individualized complex-waveform HD-tACS to quantify PAC changes and attempt to align gamma activity with alpha troughs to improve perception. The first aim focuses on contrast sensitivity in V1, while the second examines 3D motion perception in MT, with 120 participants per study. The project seeks mechanistic insight into age-related perceptual decline and potential remediation strategies with implications for ADRD.

Why it matters

Potential benefit: If successful, participants could experience improvements in specific visual perceptions affected by aging and gain insight into noninvasive methods to support vision in older adults.

How similar studies have gone: Previous work in noninvasive brain stimulation and rhythm-based perceptual modulation has shown promise, but this exact PAC-targeted, personalized approach is exploratory in aging vision.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18+ years of age or older
* normal or corrected-to-normal visual acuity, color vision, and stereo vision

Exclusion Criteria:

* not pregnant,
* no metal implants in head,
* no implanted electronic devices,
* no history of neurological problems or head injury,
* no skin sensitivity,
* no claustrophobia,
* no dementia (normal Mini Mental State Examination between 24-30; Montreal Cognitive Assessment \> 25)
* no depression (normal Beck Depression Inventory II \<13; Geriatric Depression Scale \< 10)
* no ophthalmological diseases (e.g., strabismus, glaucoma, cataract, macular degeneration)
* no history of psychosis
* no cognitive deficits (MMSE score\>24; MoCA\>25)
* cannot be taking any psychoactive medication.

Where it's running

  • 111 Cummington Mall, Boston University
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.